Donepezil use in managed Medicare: effect on health care costs and utilization.

Fillit, H; Gutterman, E M; Lewis, B

Fillit, H; Gutterman, E M; Lewis, B.

Affiliation

Fillit H; Institute for the Study of Aging, Inc., and Department of Geriatrics, Medicine and Neurobiology, Mount Sinai Medical Center, New York, New York 10153, USA.

Clin Ther ; 21(12): 2173-85, 1999 Dec.

Article in En | MEDLINE | ID: mdl-10645761

Subject(s)

Alzheimer Disease/economics; Cholinesterase Inhibitors/economics; Indans/economics; Nootropic Agents/economics; Piperidines/economics; Aged; Aged, 80 and over; Alzheimer Disease/drug therapy; Cholinesterase Inhibitors/therapeutic use; Donepezil; Drug Prescriptions/economics; Drug Utilization; Female; Health Care Costs; Humans; Indans/therapeutic use; Male; Managed Care Programs; Nootropic Agents/therapeutic use; Piperidines/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Cholinesterase Inhibitors / Nootropic Agents / Alzheimer Disease / Indans Type of study: Health_economic_evaluation Aspects: Implementation_research Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Clin Ther Year: 1999 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links